Related Experiment Video
Updated: Sep 30, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Psychiatric Comorbidity in Research on Medications for Opioid Use Disorder: A Systematic Review
Victoria Ameral1,2, Amanda K Falcón1,2, Noah R Wolkowicz3,4
1VISN 1 Mental Illness Research, Education, and Clinical Center (MIRECC), VA Bedford Healthcare System, Bedford.
Introduction:
Co-occurring psychiatric conditions are common in opioid use disorder (OUD). This review summarizes findings on the effects of co-occurring conditions on OUD outcomes and changes in psychiatric symptoms during medication treatment for OUD.
Methods:
The initial search yielded 6,419 articles from PubMed, Embase, Health & Medical Collection, CINAHL, APA PsycINFO, and Medline databases, and 76 of which were eligible for study inclusion. All articles were coded by independent raters, and consensus was used for the final results.
Results:
Most of the identified studies reported no effect of baseline mental health diagnoses or symptoms on substance use or treatment retention. Studies that examined changes in psychiatric symptoms over time largely reported improvement in mental health during medication treatment.
Conclusions:
While there is some evidence that mental health symptoms improve during treatment, medications for OUD are likely insufficient on their own for addressing co-occurring mental health conditions.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Analgesia and Pain Management
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
